VTAKA little corporate geometry
Catheter Precision just got stockholder approval for all six proposals on the table at a special meeting Wednesday, according to an SEC filing-backed statement. The headline item: the company can issue common shares tied to its Series C-1, C-2, C-3, and C-4 convertible preferred stock.
Translation: more shares may be coming
If you’ve ever seen a company try to juggle financing, this is one of those “please bear with our cap table” moments. Convertible preferred stock can eventually turn into common shares, which usually means the share count could climb — and existing holders may feel a little squeezed.
Why the reverse split matters
The other eyebrow-raiser here is the reverse split approval. Those usually show up when a stock is trying to boost its per-share price, often to stay in compliance with listing rules or make the optics less, well, penny-stock-y.
Big picture
For investors, this is less about a growth spark and more about capital structure housekeeping. Helpful for the company’s flexibility? Sure. A loud reminder that dilution risk is still very much in the chat? Also yes.